Are Patients With Fibromyalgia in a Prothrombotic State?

Biol Res Nurs. 2019 Mar;21(2):224-230. doi: 10.1177/1099800418824716. Epub 2019 Jan 17.

Abstract

Objectives: The aim of this study was to investigate thrombosis-related parameters (blood coagulation parameters, platelet indices, red blood cell [RBC] count, and inflammatory markers) in patients with fibromyalgia (FM).

Method: We carried out a case-control study with 35 women with FM and 12 age-matched healthy volunteers to analyze fibrinogen levels, prothrombin time, cephaline time, platelet count, platelet distribution width (PDW), mean platelet volume (MPV), RBC count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio (PLR).

Results: The results showed significantly increased fibrinogen levels ( p < .05), platelet count ( p < .05), PDW ( p = .059), RBC count ( p < .05), and PLR ( p < .05) in women with FM versus the healthy volunteers. Prothrombin time ( p < .05) and MPV ( p < .05) were significantly lower in patients with FM than in the controls.

Conclusions: Elevated platelet and RBC counts, PDW values, and fibrinogen levels as well as decreased prothrombin time are all indicative of a prothrombotic state in FM patients, which may be enhanced by an increased inflammatory tone. This prothrombotic state may increase the risk of thrombosis-related cardiovascular disease in patients with FM.

Keywords: fibrinogen; fibromyalgia; inflammation; platelets; prothrombin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Case-Control Studies
  • Female
  • Fibromyalgia / blood*
  • Fibromyalgia / pathology*
  • Humans
  • Inflammation / blood*
  • Inflammation / pathology
  • Lymphocytes / pathology
  • Mean Platelet Volume
  • Middle Aged
  • Neutrophils / pathology
  • Platelet Count
  • Prothrombin / analysis*
  • Thrombosis / diagnosis*
  • Thrombosis / pathology*

Substances

  • Biomarkers
  • Prothrombin